| ||||
Public Act 103-0238 | ||||
| ||||
| ||||
AN ACT concerning animals.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 1. Short title. This Act may be cited as the | ||||
Protection of Dogs and Cats from Unnecessary Testing Act. | ||||
Section 5. Definitions. In this Act: | ||||
"Alternative test method" means a test method that does | ||||
not use animals, or in some cases reduces or refines the use of | ||||
animals, for which the reliability and relevance for a | ||||
specific purpose has been established by validation bodies, | ||||
including, but not limited to, the Inter-Agency Coordinating | ||||
Committee for the Validation of Alternative Methods and the | ||||
Organisation for Economic Co-operation and Development. | ||||
Alternative test methods include, but are not limited to, | ||||
high-throughput screening methods, testing of categories of | ||||
chemical substances, tiered testing methods, in vitro studies, | ||||
and systems biology.
| ||||
"Cat" means a small domesticated carnivorous mammal that | ||||
is a member of the family Felidae, order Carnivora.
| ||||
"Canine or feline toxicological experiment" means any test | ||||
or study of any duration that seeks to determine the effect, if | ||||
any, of the application or exposure, whether internal or | ||||
external, of any amount of a chemical substance on a dog or |
cat. "Application or exposure" includes, but is not limited | ||
to, oral ingestion, skin or eye contact, or inhalation. | ||
"Application or exposure" does not include testing of | ||
veterinary products for canine or feline health.
| ||
"Chemical substance" means any organic or inorganic | ||
substance, including, but not limited to, a drug, as defined | ||
in Section 321(g) of Title 21 of the United States Code, a | ||
pesticide, as defined in Section 136(u) of Title 7 of the | ||
United States Code, a chemical substance, as defined in | ||
Section 2602(2) of Title 15 of the United States Code, or a | ||
food additive, as defined in Section 321(s) of Title 21 of the | ||
United States Code.
| ||
"Testing facility" means any partnership, corporation, | ||
association, school, institution, organization, or other legal | ||
relationship, whether privately or government owned, leased, | ||
or operated, that tests chemicals, ingredients, product | ||
formulations, or products in this State.
| ||
"Dog" means any member of the species Canis familiaris.
| ||
"Medical research" means research related to the causes, | ||
progression, diagnosis, treatment, control, or prevention of | ||
physical or mental diseases and impairments or chronic | ||
conditions of humans or animals or related to the development | ||
of biomedical products or devices, as defined under Section | ||
321(h) of Title 21 of the United States Code. Medical research | ||
does not include research related to the development of drugs | ||
as defined in Section 321(g)(1) of Title 21 of the United |
States Code.
| ||
Section 10. Prohibition on the use of dogs or cats in | ||
toxicological experiments; exemptions; enforcement.
| ||
(a) Notwithstanding any law to the contrary, and in | ||
addition to the prohibitions set forth in law, a testing | ||
facility shall not conduct a canine or feline toxicological | ||
experiment in this State unless the experiment is conducted | ||
for any of the following purposes:
| ||
(1) Medical research.
| ||
(2) To comply with federal requirements pertaining to | ||
the approval or maintenance of a medical device, as | ||
defined under Section 321(h) of Title 21 of the United | ||
States Code.
| ||
(3) To achieve discovery, approval, or maintenance of | ||
a drug, pursuant to a testing requirement imposed by the | ||
United States Food and Drug Administration under Section | ||
505 or 512 of the Federal Food, Drug, and Cosmetic Act or | ||
Section 351 of the Public Health Service Act or any | ||
binding agency regulation promulgated upon notice and | ||
comment thereunder, if the United States Food and Drug | ||
Administration has not otherwise expressly authorized drug | ||
manufacturers to use alternative test methods.
| ||
(4) To achieve discovery, approval, or maintenance of | ||
a biologic, pursuant to a testing requirement imposed by | ||
the United States Department of Agriculture under the |
Virus-Serum-Toxin Act or any binding agency regulation | ||
promulgated upon notice and comment thereunder, if the | ||
United States Department of Agriculture has not concluded | ||
that waivers shall be granted for the experimentation or | ||
studies or expressly indicated acceptance of alternative | ||
test methods.
| ||
(5) To achieve discovery, approval, registration, or | ||
maintenance of a pesticide, pursuant to a testing | ||
requirement imposed by the United States Environmental | ||
Protection Agency pursuant to the Federal Insecticide, | ||
Fungicide, and Rodenticide Act, or any binding agency | ||
regulation promulgated upon notice and comment thereunder, | ||
if the Environmental Protection Agency has not concluded | ||
that waivers shall be granted for such experimentation or | ||
studies or expressly indicated acceptance of alternative | ||
test methods.
| ||
(6) To comply with a requirement to conduct the | ||
experiment under the Toxic Substances Control Act, if the | ||
United States Environmental Protection Agency has not, | ||
pursuant to Section 2603(h) of Title 15 of the United | ||
States Code, concluded that waivers shall be granted for | ||
such experimentation or studies or expressly indicated | ||
acceptance of testing methods alternative to laboratory | ||
animal testing, including, but not limited to, in vitro, | ||
in silico, and in chemico approaches for identifying skin | ||
sensitization hazards.
|
(b)(1) The Attorney General or a State's Attorney in the | ||
county in which a violation of this Act occurred may bring an | ||
action in the name of the People of the State to enforce the | ||
provisions of this Act.
| ||
(2) Whenever the Attorney General, or a State's Attorney | ||
in the county in which a violation of this Act occurred, has | ||
reason to believe that a testing facility has in engaged in or | ||
is engaging in any practice in violation of this Act, and that | ||
proceedings would be in the public interest, he or she may | ||
bring an action in the name of the People of the State against | ||
such testing facility to restrain by preliminary or permanent | ||
injunction the use of that practice.
| ||
(3) If the court determines that the Attorney General or | ||
State's Attorney is the prevailing party in an action filed | ||
pursuant to paragraph (1), the official may recover a civil | ||
penalty not to exceed $5,000 for each day that each dog or each | ||
cat is used in a canine or feline toxicological experiment in | ||
violation of this Section. In addition to the civil penalty, | ||
the official may also recover court costs and attorney's fees.
| ||
(c) The prohibition in subsection (a) does not apply to | ||
testing or experimentation conducted for the purpose of | ||
developing, manufacturing, or marketing any product intended | ||
for beneficial use in dogs or cats.
| ||
Section 97. Severability. The provisions of this Act are | ||
severable under Section 1.31 of the Statute on Statutes. |
Section 99. Effective date. This Act takes effect upon | ||
becoming law.
|